Amgen, Inc. (AMGN) Posts Solid Q3 Results; Boosts Buyback to $10B; Raises FY11 EPS Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. NVDA
2. PCVX
3. SPY
4. PTC
5. META
6. MSFT
7. AMD
8. AMZN
9. GMAB
10. ATH

October 24, 2011 4:07 PM EDT
Amgen, Inc. (NASDAQ: AMGN) reported Q3 EPS of $1.40, $0.10 better than the analyst estimate of $1.30. Revenue for the quarter came in at $3.94 billion versus the consensus estimate of $3.87 billion.

Raised its buyback program to $10 billion.

Amgen, Inc. sees FY2011 EPS of $5.15-$5.30, versus prior guidance of $5.00-$5.20 and the consensus of $5.21. Amgen, Inc. sees FY2011 revenue of $15.4-$15.6 billion, versus prior guidance of $15.1-$15.5 billion and the consensus of $15.43 billion.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance, Hot Earnings, Hot Guidance, Stock Buybacks